Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macu...

por Huber, Anna Lena, Angermann, Reinhard, Nowosielski, Yvonne, Seifarth, Christof, Kralinger, Martina T., Zehetner, Claus
Publicado 2021

Long-term persistence with aflibercept therapy among treatment-naïve patients with exudative age-related macular degeneration in a universal health care system: a retrospective stu...

por Angermann, Reinhard, Franchi, Alexander, Frede, Katharina, Stöckl, Victoria, Palme, Christoph, Kralinger, Martina, Zehetner, Claus
Publicado 2022

Efficiency benchmarks in the surgical management of primary rhegmatogenous retinal detachment: a monocentric register cohort study of operating room time metrics and influential fa...

por Angermann, Reinhard, Huber, Anna Lena, Hofer, Markus, Nowosielski, Yvonne, Egger, Stefan, Kralinger, Martina T, Zehetner, Claus
Publicado 2021

Systemic counterregulatory response of angiopoietin‐2 after aflibercept therapy for nAMD: a potential escape mechanism

por Angermann, Reinhard, Rauchegger, Teresa, Nowosielski, Yvonne, Seifarth, Christof, Egger, Stefan, Kralinger, Martina T., Kieselbach, Gerhard F., Zehetner, Claus
Publicado 2020

CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

por Angermann, Reinhard, Huber, Anna Lena, Nowosielski, Yvonne, Salcher, Stefan, Gasser, Thomas, Seifarth, Christof, Kralinger, Martina T., Zehetner, Claus
Publicado 2022

Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up Investigation

por Angermann, Reinhard, Franchi, Alexander, Stöckl, Victoria, Rettenwander, Julia, Rettenwander, Tanja, Goldin, David, Stattin, Martin, Kralinger, Martina T., Zehetner, Claus
Publicado 2022